Skip to main content
Click Here For COVID-19 Studies
Home
Clinical Trials Office Register as a Researcher Log In
236 Studies Now Enrolling
 Menu
Home How It Works Resources Join RecruitMe

Search

Reset

Status

  • Closed (3)

Medical Condition

  • Show all (223)
  • Addiction (6)
  • Autoimmune Disorders (15)
  • Blood Disorders (23)
    • Amyloidosis (9)
    • Anemia (1)
    • (-) Sickle Cell Disease (1)
  • Bone & Muscle (1)
  • Cancer (3)
  • Child Development (1)
  • Endocrine & Metabolic Disease (2)
  • Hair and Skin Disorders (2)
  • Healthy Volunteers (8)
  • Heart Disease (1)
  • Liver Disease (1)
  • Lung Disease (1)
  • Meniere's Disease (1)
  • Neurological Disorders (102)
  • Obstetrics & Gynecology (3)
  • Pediatrics (5)
  • Psychiatric Disorders (48)
    • ADD/ADHD (2)
    • Anxiety (4)
    • Bipolar Disorder (6)
    • Borderline Personality Disorder (1)
    • Depression (19)
    • Eating Disorders (3)
    • Obsessive Compulsive Disorder (OCD) (5)
    • PTSD (2)
    • (-) Schizophrenia (2)
Displaying 1 - 3 of 3

A Study to Test if TV-46000 is Effective for Maintenance Treatment of Schizophrenia

Condition: Psychiatric Disorders / Schizophrenia
Investigator: Joshua Kantrowitz, Md
Status: Closed
The purpose of this study is to evaluate the efficacy, safety and tolerability of different doses and durations of TV-46000 given by subcutaneous (under the skin) injection as compared to placebo for use as a potential maintenance in adults with schizophrenia.
Read More

Study of EDIT-301 in Patients with Severe Sickle Cell Disease (SCD)

Condition: Blood Disorders / Sickle Cell Disease
Investigator: Monica Bhatia, MD
Status: Closed
The purpose of this study is to find out if the study medicine called EDIT-301 will help in the treatment of Severe Sickle Cell Disease (SCD) and how safe it is to be used in people. EDIT-301 (study medicine) is a new investigational therapy which uses the patient's own stem cells, modifies them by CRISPR technology, and infuses them back to the…
Read More

Lumateperone for Schizophrenia

Condition: Psychiatric Disorders / Schizophrenia
Investigator: Jeffrey Lieberman, MD
Status: Closed
This study plans to learn more about an investigational new drug called lumateperone tosylate (ITI-007) and may help us find new types of treatment for schizophrenia and schizoaffective disorder.
Read More
COMPLIANCE
Compliance Hotline Compliance Program
RESOURCES
Terms of Use Privacy Policy ©2026 Columbia University
SCHOOLS
Vagelos College of Physicians and Surgeons Mailman School of Public Health School of Nursing College of Dental Medicine Graduate School of Arts and Science